Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Deferred tax assets by Year
Deferred tax assets — Accrued expenses, reserves & other ($M) ($M)
Vertex Pharmaceuticals Deferred tax assets: $234M in FY2025, up 21.6% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Income Taxes).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred tax assets — Accrued expenses, reserves & other ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 234 | +21.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 192 | +31.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 147 | 0.0% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 147 | +62.3% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 90.3 | +308.6% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 22.1 | +157.0% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 8.60 | +26.5% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 6.80 | +19.3% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 5.70 | – | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 0 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Deferred tax assets ($M), annual FY2016–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/dta-other
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.